Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11026)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Aug 28, 2017 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ntavatzikos A, Spathis A, Patapis P, Machairas N, Peros G, Konstantoudakis S, Leventakou D, Panayiotides IG, Karakitsos P, Koumarianou A. Integrating TYMS, KRAS and BRAF testing in patients with metastatic colorectal cancer. World J Gastroenterol 2017; 23(32): 5913-5924 [PMID: 28932083 DOI: 10.3748/wjg.v23.i32.5913] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v23/i32/5913.htm |
| Number | Citing Articles |
| 1 |
Yassine Khalij, Imtinen Belaid, Sana Chouchane, Dorra Amor, Asma Omezzine, Nabila Ben rejeb, Slim ben Ahmed, Ali Bouslama. DPYDandTYMSpolymorphisms as predictors of 5 fluorouracil toxicity in colorectal cancer patients. Journal of Chemotherapy 2023; 35(5): 425 doi: 10.1080/1120009X.2022.2125736
|
| 2 |
G. Carlsson, A. Koumarianou, T.K. Guren, J. Haux, P. Katsaounis, N. Kentepozidis, P. Pfeiffer, M. Brændengen, D. Mavroudis, H. Taflin, L. Skintemo, R. Tell, C. Papadimitriou. A phase I/II study of arfolitixorin and 5-fluorouracil in combination with oxaliplatin (plus or minus bevacizumab) or irinotecan in metastatic colorectal cancer. ESMO Open 2022; 7(5): 100589 doi: 10.1016/j.esmoop.2022.100589
|
| 3 |
Charalampia Ioannou, Georgia Ragia, Ioanna Balgkouranidou, Nikolaos Xenidis, Kyriakos Amarantidis, Triantafyllia Koukaki, Eirini Biziota, Stylianos Kakolyris, Vangelis G Manolopoulos.
Gender-Dependent Association of
Tyms
-TSER Polymorphism With 5-Fluorouracil or Capecitabine-Based Chemotherapy Toxicity
. Pharmacogenomics 2021; 22(11): 669 doi: 10.2217/pgs-2021-0031
|
| 4 |
Shuai Li, Jingyuan Zhao, Linlin Lv, Deshi Dong. Identification and Validation of TYMS as a Potential Biomarker for Risk of Metastasis Development in Hepatocellular Carcinoma. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.762821
|
| 5 |
Li Guo, Yaodong Zhang, Zibo Yin, Yaya Ji, Guowei Yang, Bowen Qian, Sunjing Li, Jun Wang, Tingming Liang, Changxian Li, Xiangcheng Li. Screening and identification of genes associated with cell proliferation in cholangiocarcinoma. Aging 2020; 12(3): 2626 doi: 10.18632/aging.102766
|
| 6 |
Hui-Zhu Qiu, Ji Huang, Cheng-Cheng Xiang, Rong Li, Er-Dong Zuo, Yuan Zhang, Li Shan, Xu Cheng. Screening and Discovery of New Potential Biomarkers and Small Molecule Drugs for Cervical Cancer: A Bioinformatics Analysis. Technology in Cancer Research & Treatment 2020; 19 doi: 10.1177/1533033820980112
|
| 7 |
Sivasankari Ramadurai, Saurav Panicker, Satish Ramalingam. Cancer Genes: Volume 2. 2023; : 202 doi: 10.2174/9789815136500123020008
|
| 8 |
Mona Kamal Eldeeb, Mai Maher Abd-Elaziz Shoaib, Esraa Ahmed Abd-Elmonem, Hesham Mahmoud Sayd Saeed, Amira Mohammad Embaby, Ayman Mohamed Farouk, Radwa Mohammed Rashad. Genetic polymorphisms and gene expression of one-carbon metabolizing enzymes and their relation to breast cancer. Egyptian Journal of Medical Human Genetics 2022; 23(1) doi: 10.1186/s43042-022-00296-8
|
| 9 |
Miao Xu, Tianxiang Ouyang, Kaiyang Lv, Xiaorong Ma. Integrated WGCNA and PPI Network to Screen Hub Genes Signatures for Infantile Hemangioma. Frontiers in Genetics 2021; 11 doi: 10.3389/fgene.2020.614195
|
| 10 |
Juan Pablo Cayún, Leslie Carol Cerpa, Alicia Colombo, Dante Daniel Cáceres, José Luis Leal, Felipe Reyes, Carolina Gutiérrez-Cáceres, Susan Calfunao, Nelson Miguel Varela, Luis Abel Quiñones. Genetic Polymorphisms and Tumoral Mutational Profiles over Survival in Advanced Colorectal Cancer Patients: An Exploratory Study. Current Oncology 2024; 31(1): 274 doi: 10.3390/curroncol31010018
|
| 11 |
Anastasios Ntavatzikos, Aris Spathis, Paul Patapis, Nikolaos Machairas, Georgia Vourli, George Peros, Iordanis Papadopoulos, Ioannis Panayiotides, Anna Koumarianou. TYMS/KRAS/BRAF molecular profiling predicts survival following adjuvant chemotherapy in colorectal cancer. World Journal of Gastrointestinal Oncology 2019; 11(7): 551-566 doi: 10.4251/wjgo.v11.i7.551
|